The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection

Journal of Surgical Oncology

Volumn 99, Issue 6, 2009, Pages 335-342

  Sae, Byeol Choi ^a   Seung, Woo Park ^a   Kyung, Sik Kim ^a   Jin, Sub Choi ^a   Woo, Jung Lee ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILIARY TRACT SURGERY; BYPASS SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LAPAROTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PANCREATICOGASTROSTOMY; PANCREATICOJEJUNOSTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; BILE DUCT TUMOR; BLOOD; CANCER INVASION; CANCER STAGING; DUODENUM TUMOR; LYMPH NODE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL; TUMOR RECURRENCE;

AGED; BILE DUCT NEOPLASMS; BILIRUBIN; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 65449163491     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21238     Document Type: Article

References (23)

1. Longmire WP, McArthur MS, Bastounis EA, et al.: Carcinoma of the extrahepatic biliary tract. Ann Surg 1973;178:333-345.
2. Japanese Society of Biliary Surgery: The general rules for surgical and pathological studies on cancer of the biliary tract, 2nd edition. Tokyo: Kanehara; 2004.
3. Jarnagin WR, Shoup M: Surgical management of cholangiocarcinoma. Semin Liver Dis 2004;24:189-199. (Pubitemid 38738347)
4. DeOliveira ML, Cunningham SC, Cameron JL, et al.: Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007;245:755-762.
5. Nagorney DM, Donohue JH, Farnell MB, et al.: Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993;128:871-877; discussion 877-879.
6. Sakamoto Y, Kosuge T, Shimada K, et al.: Prognostic factors of surgical resection in middle and distal bile duct cancer: An analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 2005;137:396-402.
7. Todoroki T, Kawamoto T, Koike N, et al.: Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg 2001;88:364-370.
8. Kayahara M, Nagakawa T, Ohta T, et al.: Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 1999;229:76-83.
9. Yoshida T, Matsumoto T, Sasaki A, et al.: Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 2002;137:69-73.
10. Kayahara M, Nagakawa T, Tsukioka Y, et al.: Neural invasion and nodal involvement in distal bile duct cancer. Hepatogastroenterology 1994;41:190-194.
11. Wakai T, Shirai Y, Moroda T, et al.: Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 2005;103:1210-1216.
12. Hong SM, Cho H, Lee OJ, et al.: The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor. Am J Surg Pathol 2005;29:1177-1183.
13. Sasaki R, Takeda Y, Funato O, et al.: Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg 2007;31:1788-1796.
14. Bosma A: Surgical pathology of cholangiocarcinoma of the liver hilus (Klatskin tumor). Semin Liver Dis 1990;10:85-90. (Pubitemid 20214603)
15. Jang JY, Kim SW, Park DJ, et al.: Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005;241:77-84.
16. Greene FL, Page DL, Fleming ID, et al.: AJCC Cancer Staging Manual, 6th edition. New York: Springer-Verlag; 2002.
17. Murakami Y, Uemura K, Hayashidani Y, et al.: Pancreatoduodenectomy for distal cholangiocarcinoma: Prognostic impact of lymph node metastasis. World J Surg 2007;31:337-342; discussion 343-344.
18. Fong Y, Blumgart LH, Lin E, et al.: Outcome of treatment for distal bile duct cancer. Br J Surg 1996;83:1712-1715.
19. Ebata T, Nagino M, Nishio H, et al.: Pancreatic and duodenal invasion in distal bile duct cancer: Paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg 2007;31:2008-2015.
20. Yoshida T, Matsumoto T, Sasaki A, et al.: Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 2004;187:736-740.
21. Hernandez J, Cowgill SM, Al-Saadi S, et al.: An aggressive approach to extrahepatic cholangiocarcinomas is warranted: Margin status does not impact survival after resection. Ann Surg Oncol 2008;15:807-814.
22. Kim S, Kim SW, Bang YJ, et al.: Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002;54:414-419.
23. Takao S, Shinchi H, Uchikura K, et al.: Liver metastases after curative resection in patients with distal bile duct cancer. Br J Surg 1999;86:327-331.